Ann: European approvals and milestone payments for Lenzetto, page-7

Fantastic news but only 1.72% rise. Hey shorters, stop selling 1 or 2 shares at the lowest price to push down price. Go short somewhere else, maybe perhaps BKL or CBA. ACR has no debt and proven income stream. Net profit of 6.7 cps and dividend of 6.0 cps. And new income streams on the way.

And to that substantial shareholder who sold down after ACR release its last axiron quarterly figures - bad move cause besides heavy losses, the shorters covered without paying a high price which affects every single shareholder.

Common, we need the support of some solid institutional investors and not let the shorters damage the value of ACR. Common, ACR - no debt and consistent net profits and dividends every year and trading at P/E of 7 to 8. Should be trading at P/E of 15 to 16.